Alzheimer's disease (AD) represents one of the most pressing healthcare challenges of our time, affecting millions globally and presenting complex pathophysiological mechanisms that extend beyond traditional amyloid-focused therapeutic approaches.
As conventional pharmacological interventions demonstrate limited efficacy, the growing understanding of AD pathophysiology has spurred the exploration of alternative, non-pharmacological interventions targeting diverse biological pathways.
Read this full work here
Genesis Scientific Publication is licensed under CC BY-NC-ND 4.0
